Cargando…

Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study

BACKGROUND: There are conflicting research results about the survival differences between hemodialysis(HD) and peritoneal dialysis (PD). The present study estimated the survival and the relative mortality hazard for incident HD and PD patients with end stage renal disease (ESRD) in eastern China. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xi, Lei, Wenhua, Shi, Nan, Lin, Weiqiang, Du, Xiaoying, Zhang, Ping, Chen, Jianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389640/
https://www.ncbi.nlm.nih.gov/pubmed/32727426
http://dx.doi.org/10.1186/s12882-020-01909-3
_version_ 1783564416448462848
author Yao, Xi
Lei, Wenhua
Shi, Nan
Lin, Weiqiang
Du, Xiaoying
Zhang, Ping
Chen, Jianghua
author_facet Yao, Xi
Lei, Wenhua
Shi, Nan
Lin, Weiqiang
Du, Xiaoying
Zhang, Ping
Chen, Jianghua
author_sort Yao, Xi
collection PubMed
description BACKGROUND: There are conflicting research results about the survival differences between hemodialysis(HD) and peritoneal dialysis (PD). The present study estimated the survival and the relative mortality hazard for incident HD and PD patients with end stage renal disease (ESRD) in eastern China. METHODS: This study examined a cohort of patients with ESRD who initiated dialysis therapy in Zhejiang province between Jan of 2010 and Dec of 2014, followed up until the end of 2015. PD patients were matched in a 1:1 fashion with HD patients, and Kaplan–Meier analysis was used to explore the survival of them. The Cox proportional hazard regression model was applied to identify the factors that predict survival by treatment modality. Subgroup analyses were conducted by stratifying patients according to gender, age, causes of ESRD and comorbidities. RESULTS: Among a total of 22,379 enrolled patients (17,029 HD patients and 5350 PD patients), 5350 matched pairs were identified, and followed for a median of 29 months (3 ~ 72 months). Kaplan-Meier survival curve revealed that overall mortality rate was significantly higher in HD patients than in PD patients (log-rank test, P < 0.001), after adjusting by gender, age, primary causes of ESRD and comorbidities. HD was consistently associated with an increased risk for morality compared with PD in the matched cohort (adjusted hazard ratio (AHR): 1.140, 95%CI: 1.023 ~ 1.271). In subgroup analyses, male, younger patients, or nondiabetic patients aged less than 65 years after adjustment of covariates, initiating with PD was associated with a significantly lower mortality compared with HD. In the multivariate Cox proportional risks model, age, diabetic nephropathy (DN), other/unknown causes of ESRD, and patients with a history of cardiovascular disease or cancer showed statistical significance in explaining survival of incident ESRD patients. CONCLUSIONS: ESRD patients who initiated dialysis with PD yielded superior survival rates compared to HD. Increased use of PD as initial dialysis modality in ESRD patients could be encouraged in Chinese population.
format Online
Article
Text
id pubmed-7389640
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73896402020-07-31 Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study Yao, Xi Lei, Wenhua Shi, Nan Lin, Weiqiang Du, Xiaoying Zhang, Ping Chen, Jianghua BMC Nephrol Research Article BACKGROUND: There are conflicting research results about the survival differences between hemodialysis(HD) and peritoneal dialysis (PD). The present study estimated the survival and the relative mortality hazard for incident HD and PD patients with end stage renal disease (ESRD) in eastern China. METHODS: This study examined a cohort of patients with ESRD who initiated dialysis therapy in Zhejiang province between Jan of 2010 and Dec of 2014, followed up until the end of 2015. PD patients were matched in a 1:1 fashion with HD patients, and Kaplan–Meier analysis was used to explore the survival of them. The Cox proportional hazard regression model was applied to identify the factors that predict survival by treatment modality. Subgroup analyses were conducted by stratifying patients according to gender, age, causes of ESRD and comorbidities. RESULTS: Among a total of 22,379 enrolled patients (17,029 HD patients and 5350 PD patients), 5350 matched pairs were identified, and followed for a median of 29 months (3 ~ 72 months). Kaplan-Meier survival curve revealed that overall mortality rate was significantly higher in HD patients than in PD patients (log-rank test, P < 0.001), after adjusting by gender, age, primary causes of ESRD and comorbidities. HD was consistently associated with an increased risk for morality compared with PD in the matched cohort (adjusted hazard ratio (AHR): 1.140, 95%CI: 1.023 ~ 1.271). In subgroup analyses, male, younger patients, or nondiabetic patients aged less than 65 years after adjustment of covariates, initiating with PD was associated with a significantly lower mortality compared with HD. In the multivariate Cox proportional risks model, age, diabetic nephropathy (DN), other/unknown causes of ESRD, and patients with a history of cardiovascular disease or cancer showed statistical significance in explaining survival of incident ESRD patients. CONCLUSIONS: ESRD patients who initiated dialysis with PD yielded superior survival rates compared to HD. Increased use of PD as initial dialysis modality in ESRD patients could be encouraged in Chinese population. BioMed Central 2020-07-29 /pmc/articles/PMC7389640/ /pubmed/32727426 http://dx.doi.org/10.1186/s12882-020-01909-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yao, Xi
Lei, Wenhua
Shi, Nan
Lin, Weiqiang
Du, Xiaoying
Zhang, Ping
Chen, Jianghua
Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study
title Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study
title_full Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study
title_fullStr Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study
title_full_unstemmed Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study
title_short Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study
title_sort impact of initial dialysis modality on the survival of patients with esrd in eastern china: a propensity-matched study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389640/
https://www.ncbi.nlm.nih.gov/pubmed/32727426
http://dx.doi.org/10.1186/s12882-020-01909-3
work_keys_str_mv AT yaoxi impactofinitialdialysismodalityonthesurvivalofpatientswithesrdineasternchinaapropensitymatchedstudy
AT leiwenhua impactofinitialdialysismodalityonthesurvivalofpatientswithesrdineasternchinaapropensitymatchedstudy
AT shinan impactofinitialdialysismodalityonthesurvivalofpatientswithesrdineasternchinaapropensitymatchedstudy
AT linweiqiang impactofinitialdialysismodalityonthesurvivalofpatientswithesrdineasternchinaapropensitymatchedstudy
AT duxiaoying impactofinitialdialysismodalityonthesurvivalofpatientswithesrdineasternchinaapropensitymatchedstudy
AT zhangping impactofinitialdialysismodalityonthesurvivalofpatientswithesrdineasternchinaapropensitymatchedstudy
AT chenjianghua impactofinitialdialysismodalityonthesurvivalofpatientswithesrdineasternchinaapropensitymatchedstudy